Zerion Pharma R&D Day – Dispersome® Drug Formulation Platform

Do you have problems with insoluble drug candidates? This new webinar highlights the use of a solubility enhancing technology that can improve performance and increase bioavailability.

Register Free: https://www.pharmtech.com/pt_w/solubility-enhancing-technology

Event Overview:

Solubility remains a huge problem in the pharmaceutical industry. The Dispersome® technology is a new solubility enhancing technology and is a compelling alternative to other solubility enhancing technologies, simply because Dispersomes® provide a better performance with respect to solubility and bioavailability increase, even of practically insoluble drugs. Dispersomes® is a drug formulation technology that is based on the use of Pharma Grade Beta-lactoglobulin (BLG) as a novel pharmaceutical excipient. The Dispersome® technology stabilizes the drug into an amorphous and highly soluble form. The webinar will give a comprehensive overview on the recent developments with the Dispersome® technology. These cover the scientific insights gained, the status on the novel excipient BLG, as well as case studies for several programs.

Key Learning Objectives:

• Understand how the Dispersome technology enhances drug solubility
• Learn from case studies how it works well across many type of small molecules

Who Should Attend:

• Pharmaceutical researchers and scientists
• CMC experts on oral drug delivery & formulation
• Business development, portfolio management and technology licensing experts
• Oral product development professionals

Speaker:

Korbinian Löbmann, PhD
CSO and Co-Founder
Zerion Pharma A/S

Dr Korbinian Löbmann is CSO and co-founder of Zerion Pharma A/S, which was established in January 2019 in Copenhagen, Denmark. He is author of more than 120 peer reviewed publications and patents. Prior to his role in Zerion Pharma, Dr. Korbinian Löbmann had an appointment as Assoc. Prof. with a research focus on solid state pharmacteutics at the University of Copenhagen, Denmark. He received his PhD degree from the School of Pharmacy, University of Otago, Dunedin, New Zealand in 2013.

Register Free: https://www.pharmtech.com/pt_w/solubility-enhancing-technology